25th Russian Pharmaceutical Forum will be taking place in St.Petersburg on 14 – 15 May, 2019. AIPM and Russian Pharmaceutical Forum celebrates 25th Anniversaries.

25th Russian Pharmaceutical Forum will take place in St.Petersburg on 14th – 15th May, 2019.  Don’t miss this unique opportunity to meet with all international and local pharmaceutical market players in Russia to discuss sector challenges and exchange the latest news!

LEADING MARKET PLAYERS’ STRATEGIES 

Pharmaceutical sector is going through the era of transformation due to multiple regulatory changes and information technologies development. Top managers of the major pharmaceutical market players will discuss possible scenarios of the budget and commercial segments of pharmaceutical drugs market in Russia.

General Directors of international and Russian pharmaceutical companies who have already confirmed to speak at RPF include:

• Oxana Monge, General Director, Sanofi Eurasia
• Elena Kartasheva, General Manager, Abbott Russia
• Eric Patrouillard, Country Manager Russia; Baltics, Belarus, CauCAR and Russia Sub-cluster Lead, Pfizer
• Marwan Akar, Vice-President and Managing Director, MSD Russia
• Ekaterina Pogodina, Managing Director, Russia & CIS, Janssen (Pharma division of Johnson & Johnson)
• Irina Panarina, General Manager, AstraZeneca Russia and Eurasia
• Vadim Muzyayev, President, OJSC Protek
• Vikram Punia, President, “Pharmasyntez” Group of Companies
• Vladimir Khristenko, President, Nanolek
• Peter Rodionov, General Manager, Geropharm

REAL WORLD EVIDENCE 

The use of Real World Evidence while collecting data on medicines effectiveness is one of the hottest trends in the development of global pharmaceutical sector. Trends in the development of this area globally and in Russia, regulatory issues, questions on building partnerships with hospitals and patient organisations will be discussed by Medical Directors from international and Russian pharmaceutical companies:

• Viacheslav Burmistrov, Medical Director, Sanofi Eurasia
• Vladimir Bulatov, Chief Scientific Officer, Novartis Pharma, Russia
• Mikhail Samsonov, Chief Medical Officer, R-Pharm 
• Dmitry Koloda, Medical Director, CIS, Takeda Pharmaceuticals
• Elizabeth Benito-Garcia, Real World Evidence Generation Leader for China and Emerging Markets, Sanofi (Paris, France)

M&A IN THE RUSSIAN PHARMACEUTICAL SECTOR

Notable M&A deals in the Russian market in 2018 and trends in the development of this segment in 2019 will be discussed during a session organised by Novus Capital. Speakers will include:

• Alexander Lobakov, Managing Partner, Novus Capital
• Boris Blank, Head of International Business Development & Licensing, Berlin-Chemie | Menarini (Germany)
• Csaba Pipei, M&A Head, Egis Pharmaceuticals Plc (Hungary)
• Mihir Chhaya, Vice President – Emerging Markets, Aurobindo Pharma (India)
• Mikhail Bekker, Director, Elbrus Capital
• Vardges Ovasapyan, Director, Industrials and Services, Direct Investments (Private Equity) Gazprombank
• Ekaterina Ryzhova, M&A Director, Valenta Pharm

The Russian Pharmaceutical Forum provides an excellent opportunity to demonstrate your expertise and achievements to 600+ sector professionals. To find out about our bespoke sponsorship and exhibition packages, please contact Rebecca Pickering on +442080045703 or rebecca@adamsmithconferences.com.

We would like to inform you that colleagues and partners of AIPM Russia are eligible for an exclusive 15% discount off the standard conference price. To claim your discount, simply complete the registration form on the event website and quote the VIP code 1177MAIPMRU